Literature DB >> 24833642

Noninducibility and late potential abolition: a novel combined prognostic procedural end point for catheter ablation of postinfarction ventricular tachycardia.

John Silberbauer1, Teresa Oloriz1, Giuseppe Maccabelli1, Dimitris Tsiachris1, Francesca Baratto1, Pasquale Vergara1, Hiroya Mizuno1, Caterina Bisceglia1, Alessandra Marzi1, Nicoleta Sora1, Fabrizio Guarracini1, Andrea Radinovic1, Manuela Cireddu1, Simone Sala1, Simone Gulletta1, Gabriele Paglino1, Patrizio Mazzone1, Nicola Trevisi1, Paolo Della Bella2.   

Abstract

BACKGROUND: Successful late potential (LP) abolition and postprocedural ventricular tachycardia (VT) noninducibility constitute significant end points after catheter ablation for VT. We investigated the prognostic impact of a combined procedural end point of VT noninducibility and LP abolition in a large series of post-myocardial infarction patients with VT. METHODS AND
RESULTS: A total of 160 (154 men, 94% with implantable cardioverter defibrillators) consecutive post-myocardial infarction patients undergoing first-time ablation procedures from 2010 to 2012 were included. Of the 159 patients surviving the procedure, 137 (86%) were either inducible or in VT at baseline and 103 (65%) had baseline LP presence, of which 79 (77%) underwent successful LP abolition. The combined end point was assessable in 155 (97%) patients. There were 50 (32%) patients with VT recurrences and 17 (11%) cardiac deaths during follow-up. Patients who fulfilled the combined end point of VT noninducibility and LP abolition compared with inducible patients exhibited a significantly lower incidence of VT recurrence (16.4% versus 47.4%; log-rank P<0.001) and cardiac death (4.1% versus 42.1%; log-rank P<0.001). Among noninducible patients, those with additional LP abolition also had a lower incidence of VT recurrence (16.4% versus 46.0%; log-rank P<0.001). After multivariate analysis, the combined end point of VT noninducibility and LP abolition (hazard ratio, 0.205, P<0.001) was independently associated with VT recurrence and cardiac death (hazard ratio, 0.106; P=0.001).
CONCLUSIONS: Achieving a combined catheter ablation procedural end point of VT noninducibility and LP abolition reduces VT recurrence rates to low levels (16%). The overall strategy was associated with a significant impact on cardiac survival.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cardiomyopathies; catheter ablation; myocardial infarction; tachycardia, ventricular

Mesh:

Year:  2014        PMID: 24833642     DOI: 10.1161/CIRCEP.113.001239

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  19 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

Review 2.  Catheter ablation of ventricular tachycardia: Lessons learned from past clinical trials and implications for future clinical trials.

Authors:  Sean D Pokorney; Daniel J Friedman; Hugh Calkins; David J Callans; Emile G Daoud; Paolo Della-Bella; Kevin P Jackson; Kalyanam Shivkumar; Samir Saba; John Sapp; William G Stevenson; Sana M Al-Khatib
Journal:  Heart Rhythm       Date:  2016-04-02       Impact factor: 6.343

Review 3.  [Epicardial VT ablation : In whom, when, how and why?]

Authors:  E Ene; P Halbfaß; K Nentwich; K Sonne; A Berkovitz; A-K Wolf; T Deneke
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-06-26

4.  Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy.

Authors:  Qi Jin; Peter Karl Jacobsen; Steen Pehrson; Xu Chen
Journal:  Clin Cardiol       Date:  2017-08-17       Impact factor: 2.882

Review 5.  Prophylactic catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Varunsiri Atti; Venkat Vuddanda; Mohit K Turagam; Praveen Vemula; Zubair Shah; Himakar Nagam; Srikanth Yandrapalli; Mohammad-Ali Jazayeri; Scott Koerber; Juan Viles Gonzalez; Andrea Natale; Luigi Di Biase; Dhanunjaya R Lakkireddy
Journal:  J Interv Card Electrophysiol       Date:  2018-04-21       Impact factor: 1.900

Review 6.  Outcomes of Catheter Ablation of Ventricular Tachycardia in the Setting of Structural Heart Disease.

Authors:  B P Betensky; F E Marchlinski
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

7.  Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.

Authors:  Shuanglun Xie; Benoit Desjardins; Maciej Kubala; Jackson Liang; Jiandu Yang; Rob J van der Geest; Robert Schaller; Michael Riley; David Callans; Erica Zado; Francis Marchlinski; Saman Nazarian
Journal:  Heart Rhythm       Date:  2018-03-02       Impact factor: 6.343

8.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 9.  Innovations in ventricular tachycardia ablation.

Authors:  Qussay Marashly; Salim N Najjar; Joshua Hahn; Graham J Rector; Muzamil Khawaja; Mihail G Chelu
Journal:  J Interv Card Electrophysiol       Date:  2022-07-25       Impact factor: 1.759

10.  Prophylactic Catheter Ablation of Ventricular Tachycardia in Ischemic Cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials Electrophysiology Collaborative Consortium for Metaanalysis - ELECTRAM Investigators.

Authors:  Kuldeep Shah; Mohit Turagam; Brijesh Patel; Andrea Natale; Dhanunjaya Lakkireddy; Jalaj Garg
Journal:  J Atr Fibrillation       Date:  2020-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.